April 15, 2022 — The Board of Directors of Centene Corporation (NYSE: CNC) issued the following statement on April 15, 2022:
Centene’s Board of Directors has accepted the resignation of Leslie V. Norwalk, Esq. as a member of the board of directors. The Board appreciates Leslie’s contribution to the company and her services.
The Board remains committed to continuing to strengthen the Corporation’s corporate governance practices. Since November 2021the company has implemented significant governance improvements, including the appointment of five new members of the board of directors, the renewal of the chairs of the nominating and governance, audit and remuneration committees, the separation of roles of CEO and chairman, the appointment of a new independent lead director, and the implementation of a mandatory retirement age.
The entire Board is united in its support for the Company’s new CEO, Sarah Londonand its highly experienced and efficient management team, all of whom are focused on executing the company’s value creation strategy.
SEC Filing Information:
On April 11, 2022, Leslie Norwalk resigned, effective immediately, as a member of the board of directors (the “Board”) of Centene Corporation (the “Company”).
Pursuant to Ms. Norwalk’s letter of resignation, which is attached as Exhibit 17.1, the Company believes that Ms. Norwalk resigned due to her disagreement with
Board governance process and board and committee leadership.
At the time of her resignation, Ms. Norwalk served on the Board’s Compliance Committee, Environmental and Social Responsibility Committee and Government and
Regulatory Affairs Committee.
As part of its ongoing commitment to strengthen the Company’s corporate governance practices, since November 2021, the Company has put in place important
governance improvements, including the appointment of five new members of the board of directors, the renewal of the chairs of the nominating and governance, audit and remuneration committees
Committees, the separation of the functions of CEO and Chairman, the appointment of a new independent lead director and the establishment of a mandatory retirement age within the Board.
Additionally, the entire Board of Directors is united in its support of the company’s new CEO, Sarah London, and her highly experienced and effective management team, all of whom are focused
on the execution of the Company’s value creation strategy.
The Company has provided Ms. Norwalk with a copy of the information contained in this current report on or before the date this current report is filed with the
Security and Exchange Commission. The Company has also given Ms. Norwalk the opportunity to provide the Company with a letter stating whether she agrees or
disagrees with the statements made in this current report and the points with which it disagrees.
About Centene Corporation
Centene Corporation, a Fortune 25 company, is a leading healthcare company committed to helping people live healthier lives. The company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, cost-effective services to government-sponsored and commercial healthcare programs, focusing on the underinsured and uninsured. Centene provides affordable, high-quality products to nearly 1 in 15 people nationwide, including Medicaid and Medicare members (including Medicare prescription drug plans) and individuals and families served by the health insurance market, the TRICARE program and people in correctional facilities. The Company also serves several international markets and contracts with other healthcare and commercial organizations to provide a variety of specialized services focused on treating the whole person. Centene is focused on long-term growth and value creation as well as developing its people, systems and capabilities to better serve its members, suppliers, local communities and government partners.
Centene uses its Investor Relations website to post important information about the Company, including information that investors may believe is important. Financial and other information about Centene is regularly posted and accessible on Centene’s Investor Relations website, https://investors.centene.com/.